Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory Board
SINGAPORE and SHANGHAI, Dec. 19, 2022 -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey...
top of page
- Oct 13, 2022
Carmine Therapeutics Announces First Close of Series A to Develop Non-viral Gene Therapy
Cambridge, MA, October 13, 2022 -- Carmine Therapeutics (“Carmine”), an EVX founded biotech company and emerging leader in non-viral gene...
- Jun 28, 2022
Cargene Biopharma Welcomes Kathy He as CEO
Cargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development SINGAPORE, BOSTON and SHANGHAI...
- Jun 1, 2022
EVX Ventures announces the official opening of EVX Nexus, its life sciences startup launchpad
SINGAPORE – 27 May 2022. EVX Ventures (“EVX”), a life sciences venture builder headquartered in Singapore with operations in Boston and...
- Jan 28, 2022
EVX Ventures | 2021 Year In Review
We are absolutely thrilled to share EVX Ventures’ 2021 Year in Review. Check out our latest Year in Review to learn more:
- Nov 2, 2021
Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments
Advancing the next generation of cell and gene therapies via a “platform of platforms” model SINGAPORE, Nov. 1, 2021 /PRNewswire/ --...
- Jun 21, 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
SINGAPORE, June 18, 2021 /PRNewswire/ -- Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies,...
- May 5, 2021
Carmine Therapeutics appoints Don Haut as CEO
CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced that Don...
- Apr 26, 2021
AltruBio Raises $63 Million Series A Round To Continue Its Company Transformation
REDWOOD CITY, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company,...
- Sep 28, 2020
Carmine Therapeutics named as one of FierceBiotech’s “Fierce 15” Biotech Companies of 2020
Carmine Therapeutics has been named as one of FierceBiotech’s “Fierce 15” Biotech companies of 2020, designating it as one of the most promi
bottom of page